Monday Dec 7 | Freshnews
PerkinElmer Launches New AlphaScreen SureFire and AlphaLISA "No Wash" ...
ASCB 2009 - PerkinElmer, Inc. , a global leader focused on the health and safety of people and the environment, today announced the expansion of its "No Wash" ALPHA Technology portfolio by introducing 46 new highly sensitive cell signaling pathway and biomarker research assay kits.
PerkinElmer Introduces Expanded Reagent, Imaging, and Detection...
ASCB 2009 PerkinElmer, Inc. , a global leader focused on the health and safety of people and the environment, today announced the introduction of a wide range of new tools to improve the speed and effectiveness of life sciences research.
Qiagen 3Q profit jumps on boost in test sales
Medicis Pharmaceutical Corp. posted a third-quarter profit on Wednesday, as sales of its skin products surged, and a research and development charge came off the books.
Marsh & McLennan 3Q profit beats expectations
Marsh & McLennan Cos. said Wednesday it returned to profitability in the third quarter amid improving earnings in its risk and insurance services division and a decline in expenses.
Garmin reports surge in 3Q profits
Navigational device maker Garmin Ltd. says profits surged in the third quarter as improved pricing and lower costs offset a drop in sales.
Public Storage 3Q results better than expected
Public Storage on Thursday reported third-quarter results that were better than analysts had expected as it benefited from more favorable foreign exchange rates.
Dolan more than doubles 3Q profit
Dolan Media Co., a provider of legal and professional publications and services, said Friday its third-quarter profit more than doubled as revenue grew sharply in its mortgage default processing services business.
CareFusion profit down, but company lifts outlook
Medical technology company CareFusion Corp. said its profit slid 28 percent in the fiscal first quarter compared to a year ago, when it posted a large gain from discontinued operations.
PerkinElmer newborn screening platform gets FDA clearance
Waltham-based lab and research gear provider PerkinElmer Inc. has been granted 510K clearance from the U.S. Food and Drug Administration for its GSP Genetic Screening Processor, part of newborn screening programs.
Thoratec 3Q profit surges on heart pump success
Heart device maker Thoratec Corp. said Wednesday that its third-quarter profit almost doubled on strong growth in its cardiovascular division.
Implied Contract Found in Mass. Tech Deal
A federal appeals court recently ruled that technology purchase deals include an implied contract under Massachusetts state law requiring buyers to make reasonable efforts to develop and promote the technology.
Royal Caribbean profit falls 44 pct in 3Q
Travelers are still vacationing, but they're spending less when they do, Royal Caribbean Cruises Ltd.
GT Solar gives early 2Q profit look, changes CEO
GT Solar International Inc. announced a preliminary second-quarter profit on Monday well ahead of what analysts had been expecting.
PerkinElmer Q3 earnings show promising outlook
PerkinElmer shares jumped in early trading Friday after the release of third quarter earnings that, despite a sharp drop in year-over-year profits, showed an improving outlook for the biotechnology and health-care technology company.
PerkinElmer Tops Zacks Estimate
PerkinElmer Inc. reported third-quarter earnings of 30 cents per share, which was 3 cents ahead of the Zacks Consensus Estimate.
Standard Pacific reports smaller 3Q loss
Homebuilder Standard Pacific Corp. on Thursday reported a much narrower third-quarter loss as it booked fewer charges to write down land values amid the housing slump.
Perkinelmer, Inc. Q3 2009 Earnings Call Transcript
Perkinelmer, Inc. October 29, 2009 5:00 pm ET Executives Dave Francisco a ' IR Rob Friel a ' Chairman, President and CEO Andy Wilson a ' SVP, CFO and Chief Accounting Officer Analysts Jeff [ph] a ' Robert Baird Dan [ph] a ' UBS Presentation Operator Good day, ladies and gentlemen, and welcome to the third quarter 2009 PerkinElmer earnings ...
PerkinElmer Sets Full-year Guidance
Health-industry supplier PerkinElmer Inc. on Thursday gave a forecast for full-year adjusted earnings that topped Wall Street expectations.
Guidance Analysts are looking for EPS of 27c on revenue of $429.7M. The consensus range is 24c-29c for EPS, and $420.7M-$440.7M for revenue, according to First Call.
PerkinElmer and Corning collaborate in development of label-free detection technologies
PerkinElmer Inc. and Corning Incorporated , today announced that the two companies have entered into a strategic agreement to advance the development of next-generation label-free detection technologies.
Also on Topix